News | January 13, 2022
Metropolis Healthcare opens MedEngage Scholarship programme
The last date to apply for this program is 18th January 2022
The last date to apply for this program is 18th January 2022
Nuvaxovid is the first protein-based Covid-19 vaccine granted approval in South Korea
ICICI Direct gives a preview on the earnings narrative for Q3FY22
The companies were evaluated via a comprehensive, in-depth assessment process that included a sustainability framework of 300 points each for – Purpose, Partnership, Planet and People
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & Director & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
TATA MD’s OmiSure is the only test approved by the ICMR for RT-PCR detection of the Omicron variant
Earlier last week the U.S. FDA had also shortened the time to receive a Pfizer booster shot from six months to five months for everyone 12 and older
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
The test kit is compatible with all standard Real-Time PCR machines with a test run time of 85 minutes. The result turnaround time, including sample collection and RNA extraction, is 130 minutes
Subscribe To Our Newsletter & Stay Updated
